CLINICAL_TRIALS
research
· 2025-12-17
Clinical Trial Update: A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity [Phase 2]
Summary
A Phase 2 clinical trial evaluating obesity with at least one weight-related comorbidity has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AstraZeneca | Conditions: Obesity or Overweight | Phase 2 | Status: COMPLETED